On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...